Corrigendum to "Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design" [212 (2019) 36-44]

Affiliations

• ¹ Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada. Electronic address: loebm@mcmaster.ca.
• ² Population Health Research Institute, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
• ³ University of the Philippines Manila, Manila, Philippines.
• ⁴ All India Institute of Medical Sciences, Delhi, India.
• ⁵ Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria.
• ⁶ FuWai Hospital, Beijing, China.
• ⁷ University of Zambia, Zambia.
• ⁸ Department of Medicine, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
• ⁹ Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Saudi Arabia.
• ¹⁰ Aga Khan University, Kenya.
• ¹¹ Mulago Hospital, Uganda.
• ¹² Sheikh Khalifa Medical City, United Arab Emirates.